How we help

Small, midsize and large multinational life sciences companies routinely engage us to:

Define and execute corporate strategy: We work closely with our clients to define and execute customized strategies to drive long-term, sustainable value. Whether it’s defining a new business model, driving growth beyond a first product, evaluating attractive adjacencies, determining how to scale the team or building franchise leadership, our team has a proven track record of helping our clients build winning strategies unique to their particular circumstances.

Expand into new markets: We help our clients expand into new geographies and market segments. This includes mature and emerging markets; prescription and consumer markets; primary and specialty care markets; chronic, acute and orphan markets; research, diagnostic and therapeutic markets; and new, innovative markets. Our market access strategies for clients open the door for growth and long-term value creation.

Execute value-creating deals: We support our clients at every stage of the deal lifecycle — from search and evaluation to execution and post-transaction integration. We have helped our life sciences clients execute more than $140 billion worth of transactions including in-licensing, out-licensing, strategic partnerships, M&A, joint ventures, divestitures and royalty monetization transactions.

Launch innovative products and services: We team up with our clients to develop commercial launch strategies in mature and emerging markets. We have demonstrated success in supporting leading pharmaceutical, biotech and device brands across all key regions. Our commercial planning and launch expertise includes pharmaceutical and biopharmaceutical drugs, vaccines, life science tools, diagnostics, and life sciences enablers e.g., CROs/CDMOs.

Optimize operations: We work closely with our clients to optimize operations, organizational structures, financials and processes across the life sciences value chain. Our work for clients has increased productivity and contributed to top- and bottom-line growth at the corporate, business unit and operational team levels in a number of life sciences sectors.

---

---